Table 3.
Complications during the median follow-up of 31 months (range: 20–68 months) in 148 living donors and 160 tumour patients undergoing resection using an upper midline incision, graded using the Clavien system
| Grade | Living donors (n = 148), n (%) | Patients (n = 160), n (%) | Total (n = 308), n (%) |
|---|---|---|---|
| I | 4 (2.7%) | 8 (5.0%) | 12 (3.9%) |
| Wound infection, n = 3 | Wound infection, n = 4 | Wound infection, n = 7 | |
| MHV partial thrombosis, n = 1 | Biliary leakage, n = 3 | Biliary leakage, n = 3 | |
| Pleural effusion, n = 1 | MHV partial thrombosis, n = 1 | ||
| Pleural effusion, n = 1 | |||
| II | 2 (1.4%) | 3 (1.9%) | 5 (1.6%) |
| Transfusion, n = 2 | Transfusion, n = 2 | Transfusion, n = 4 | |
| Mechanical ileus, n = 1 | Mechanical ileus, n = 1 | ||
| IIIa | 0 | 2 (1.3%) | 2 (0.6%) |
| Biloma, n = 2 | Biloma, n = 2 | ||
| IIIb | 4 (2.7%) | 1 (0.6%) | 5 (1.6%) |
| Bleeding, n = 2 | Bleeding, n = 1 | Bleeding, n = 3 | |
| Pleural effusion, n = 1 | Pleural effusion, n = 1 | ||
| Biliary stricture, n = 1 | Biliary stricture, n = 1 | ||
| IVa | 0 | 0 | 0 |
| IVb | 0 | 0 | 0 |
| V | 0 | 1 (0.6%) | 0 |
| Heart failure, n = 1 | |||
| Total | 10 (6.8%) | 15 (9.4%) | 25 (8.1%) |
MHV, middle hepatic vein.